Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxyurea in Adult Hemoglobin SC Disease
NCT02640573Phase 2Terminated
- Sponsor
- Baylor College of Medicine
- Start
- Oct 2015
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyurea in hemoglobin SC disease (HbSC), sponsored by Baylor College of Medicine. Started Oct 2015; status: terminated.
02
Drugs
hydroxyurea
03
Conditions
hemoglobin SC disease (HbSC)
Beyond the preview
Go deeper on NCT02640573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02640573.